Metabolic syndrome, obesity, and gastrointestinal cancer

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Fujihara, Shintaro ^a   Mori, Hirohito ^a   Kobara, Hideki ^a   Nishiyama, Noriko ^a   Kobayashi, Mitsuyoshi ^a   Oryu, Makoto ^a   Masaki, Tsutomu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; RESISTIN; SOMATOMEDIN; SOMATOMEDIN C; TOLL LIKE RECEPTOR 2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

ABDOMINAL OBESITY; ADIPOCYTE; ADIPOSE TISSUE; AGE DISTRIBUTION; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL INTERACTION; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; DIABETES MELLITUS; DIGESTIVE SYSTEM CANCER; EPIGENETICS; EPITHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; GALLBLADDER CARCINOMA; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERINSULINEMIA; HYPERTENSION; IMMUNOMODULATION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIVER CELL CARCINOMA; LIVER FIBROSIS; MACROPHAGE; METABOLIC SYNDROME X; MICROALBUMINURIA; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PANCREAS ADENOCARCINOMA; PREVALENCE; STOMACH ADENOCARCINOMA; VASCULAR DISEASE; WAIST CIRCUMFERENCE;

EID: 84872141801     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/483623     Document Type: Article

References (119)

1. Wingard D. L., Barrett Connor E., Criqui M. H., Suarez L., Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. American Journal of Epidemiology 1983 117 1 19 26 2-s2.0-0020679457 (Pubitemid 13184218)
2. Reaven G. M., Role of insulin resistance in human disease. Diabetes 1988 37 12 1595 1607 2-s2.0-0024160877 (Pubitemid 19004941)
3. Alberti K. G., Zimmet P. Z., WHO Consultation, Definition, diagnosis, and classification of diabetes mellitus and its complications-part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetes Medicine 1998 15 539 553 (Pubitemid 28319935)
4. Isomaa B., Almgren P., Tuomi T., Forsén B., Lahti K., Nissén M., Taskinen M. R., Groop L., Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24 4 683 689 2-s2.0-0034837376 (Pubitemid 32893993)
5. Cleeman J. I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Journal of the American Medical Association 2001 285 19 2486 2497 2-s2.0-0035897696 (Pubitemid 32433843)
6. DeFronzo R. A., Ferrannini E., Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991 14 3 173 194 2-s2.0-0026021161
7. Lindsay R. S., Howard B. V., Cardiovascular risk associated with the metabolic syndrome. Current Diabetes Reports 2004 4 1 63 68 2-s2.0-1642360692 (Pubitemid 39359512)
8. Koh K. K., Han S. H., Quon M. J., Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. Journal of the American College of Cardiology 2005 46 11 1978 1985 2-s2.0-28244466397 10.1016/j.jacc.2005.06.082 (Pubitemid 41713578)
9. Ridker P. M., Buring J. E., Cook N. R., Rifai N., C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003 107 3 391 397 2-s2.0-0037469255
10. Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R. P., Haffner S. M., Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 2000 102 1 42 47 2-s2.0-0034604248 (Pubitemid 30430551)
11. Ridker P. M., Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003 107 3 363 369 2-s2.0-0037469177 10.1161/01.CIR.0000053730.47739.3C (Pubitemid 36158034)
12. Pradhan A. D., Manson J. E., Rifai N., Buring J. E., Ridker P. M., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 2001 286 3 327 334 2-s2.0-0035908632 (Pubitemid 32656163)
13. Festa A., D'Agostino R., Tracy R. P., Haffner S. M., Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002 51 4 1131 1137 2-s2.0-0036230414 (Pubitemid 34438360)
14. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series 2000 894 1 253
15. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 2-s2.0-2942650969 10.1210/jc.2004-0395 (Pubitemid 38766330)
16. Vohl M. C., Sladek R., Robitaille J., Gurd S., Marceau P., Richard D., Hudson T. J., Tchernof A., A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obesity Research 2004 12 8 1217 1222 2-s2.0-6344260341 (Pubitemid 41137463)
17. Zheng W., McLerran D. F., Rolland B., Zhang X., Inoue M., Matsuo K., He J., Gupta P. C., Ramadas K., Tsugane S., Irie F., Tamakoshi A., Gao Y. T., Wang R., Shu X. O., Tsuji I., Kuriyama S., Tanaka H., Satoh H., Chen C. J., Yuan J. M., Yoo K. Y., Ahsan H., Pan W. H., Gu D., Pednekar M. S., Sauvaget C., Sasazuki S., Sairenchi T., Yang G., Xiang Y. B., Nagai M., Suzuki T., Nishino Y., You S. L., Koh W. P., Park S. K., Chen Y., Shen C. Y., Thornquist M., Feng Z., Kang D., Boffetta P., Potter J. D., Association between body-mass index and risk of death in more than 1 million Asians. New England Journal of Medicine 2011 364 8 719 729 2-s2.0-79951997878 10.1056/NEJMoa1010679
18. Van Kruijsdijk R. C. M., Van Der Wall E., Visseren F. L. J., Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiology Biomarkers and Prevention 2009 18 10 2569 2578 2-s2.0-70350098099 10.1158/1055-9965.EPI- 09-0372
19. Gami A. S., Witt B. J., Howard D. E., Erwin P. J., Gami L. A., Somers V. K., Montori V. M., Metabolic syndrome and risk of incident cardiovascular events and death. A systematic review and meta-analysis of longitudinal studies. Journal of the American College of Cardiology 2007 49 4 403 414 2-s2.0-33846365989 10.1016/j.jacc.2006.09.032 (Pubitemid 46135879)
20. Ford E. S., Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S. Diabetes Care 2005 28 11 2745 2749 2-s2.0-30544433479 10.2337/diacare.28.11.2745 (Pubitemid 43951170)
21. Grundy S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A., Gordon D. J., Krauss R. M., Savage P. J., Smith S. C., Spertus J. A., Costa F., Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005 112 17 2735 2752 2-s2.0-27444443876 10.1161/CIRCULATIONAHA.105.169404 (Pubitemid 41532612)
22. The Examination Committee of the Criteria for Metabolic Syndrome in Japan, Definition and criteria of the metabolic syndrome in Japan Japan Internal Medicine 2005 94 188 201
23. International Diabetes Federation, The IDF Consensus Worldwide Definition of the Metabolic Syndrome. International Diabetes Federation, Belgium, Brussels, 2006
24. Pelucchi C., Negri E., Talamini R., Levi F., Giacosa A., Crispo A., Bidoli E., Montella M., Franceschi S., La Vecchia C., Metabolic syndrome is associated with colorectal cancer in men. European Journal of Cancer 2010 46 10 1866 1872 2-s2.0-77953288140 10.1016/j.ejca.2010.03.010
25. Ahmed R. L., Schmitz K. H., Anderson K. E., Rosamond W. D., Folsom A. R., The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006 107 1 28 36 2-s2.0-33745401508 10.1002/cncr.21950 (Pubitemid 43941640)
26. Hamaguchi M., Kojima T., Takeda N., Nakagawa T., Taniguchi H., Fujii K., Omatsu T., Nakajima T., Sarui H., Shimazaki M., Kato T., Okuda J., Ida K., The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Annals of Internal Medicine 2005 143 10 722 I70 2-s2.0-28044446543
27. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., Natale S., Vanni E., Villanova N., Melchionda N., Rizzetto M., Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003 37 4 917 923 2-s2.0-0037382786 10.1053/jhep.2003.50161 (Pubitemid 36397405)
28. Welzel T. M., Graubard B. I., Zeuzem S., El-Serag H. B., Davila J. A., Mcglynn K. A., Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-medicare database. Hepatology 2011 54 2 463 471 2-s2.0-79960747094 10.1002/hep.24397
29. Calle E. E., Rodriguez C., Walker-Thurmond K., Thun M. J., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. New England Journal of Medicine 2003 348 17 1625 1638 2-s2.0-0037464510 10.1056/NEJMoa021423 (Pubitemid 36459468)
30. Ford E. S., Giles W. H., Dietz W. H., Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. Journal of the American Medical Association 2002 287 3 356 359 2-s2.0-0037116641 (Pubitemid 34251969)
31. Ford E. S., Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S. Diabetes Care 2005 28 11 2745 2749 2-s2.0-30544433479 10.2337/diacare.28.11.2745 (Pubitemid 43951170)
32. Wilson P. W. F., D'Agostino R. B., Parise H., Sullivan L., Meigs J. B., Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005 112 20 3066 3072 2-s2.0-30944451953 10.1161/CIRCULATIONAHA.105.539528 (Pubitemid 43113437)
33. Invitti C., Gilardini L., Viberti G., Davis T. M. E., Ee C. K., Weiss R., Yeckel C. W., Caprio S., Obesity and the metabolic syndrome in children and adolescents. New England Journal of Medicine 2004 351 11 1146 1148 2-s2.0-19244365668 10.1056/NEJM200409093511119 (Pubitemid 39167521)
34. Roseboom T. J., Van der Meulen J. H. P., Ravelli A. C. J., Osmond C., Barker D. J. P., Bleker O. P., Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview. Twin Research 2001 185 1-2 93 98 (Pubitemid 33103957)
35. Barouki R., Gluckman P. D., Grandjean P., Developmental origins of non-communicable disease: implications for research and public health. Environmental Health 2012 11 42
36. Skinner M. K., Manikkam M., Guerrero-Bosagna C., Epigenetic transgenerational actions of endocrine disruptors. Reproductive Toxicology 2011 31 3 337 343 2-s2.0-79953752954 10.1016/j.reprotox.2010.10.012
37. Wajchenberg B. L., Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews 2000 21 6 697 738 2-s2.0-0034504237 10.1210/er.21.6.697 (Pubitemid 32113289)
38. John B. J., Irukulla S., Abulafi A. M., Kumar D., Mendall M. A., Systematic review: adipose tissue, obesity and gastrointestinal diseases. Alimentary Pharmacology and Therapeutics 2006 23 11 1511 1523 2-s2.0-33646592565 10.1111/j.1365-2036.2006.02915.x (Pubitemid 43727458)
39. Hursting S. D., Hursting M. J., Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 1766 1770
40. Argilés J. M., López-Soriano F. J., Insulin and cancer. International Journal of Oncology 2001 18 4 683 687 2-s2.0-0035318271
41. Watkins L. F., Lewis L. R., Levine A. E., Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. International Journal of Cancer 1990 45 2 372 375 2-s2.0-0025139803 (Pubitemid 20061396)
42. Koenuma M., Yamori T., Tsuruo T., Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Japanese Journal of Cancer Research 1989 80 1 51 58 2-s2.0-0024810688 (Pubitemid 20027198)
43. Bjork J., Nilsson J., Hultcrantz R., Johansson C., Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT29. Scandinavian Journal of Gastroenterology 1993 28 10 879 884 2-s2.0-0027517455 (Pubitemid 23294761)
44. Kaaks R., Lukanova A., Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proceedings of the Nutrition Society 2001 60 1 91 106 2-s2.0-0035123520 (Pubitemid 32183103)
45. Aaronson S. A., Growth factors and cancer. Science 1991 254 5035 1146 1153 2-s2.0-0026316096 (Pubitemid 21917439)
46. Grau M. V., Rees J. R., Baron J. A., Chemoprevention in gastrointestinal cancers: current status. Basic and Clinical Pharmacology and Toxicology 2006 98 3 281 287 2-s2.0-33645216724 10.1111/j.1742-7843.2006.pto-294.x
47. Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Ascherio A., Willett W. C., Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Annals of Internal Medicine 1994 121 4 241 246 2-s2.0-0028556801
48. Poullis A., Foster R., Shetty A., Fagerhol M. K., Mendall M. A., Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiology Biomarkers and Prevention 2004 13 2 279 284 2-s2.0-1242269322 10.1158/1055-9965.EPI-03-0160 (Pubitemid 38222561)
49. Kadowaki T., Hara K., Yamauchi T., Terauchi Y., Tobe K., Nagai R., Molecular mechanism of insulin resistance and obesity. Experimental Biology and Medicine 2003 228 10 1111 1117 2-s2.0-0242694056 (Pubitemid 37413667)
50. Giovannucci E., Insulin and colen cancer. Cancer Causes and Control 1995 6 2 164 179 2-s2.0-0028987002 10.1007/BF00052777
51. Ma J., Pollak M. N., Giovannucci E., Chan J. M., Tao Y., Hennekens C. H., Stampfer M. J., Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. Journal of the National Cancer Institute 1999 91 7 620 625 2-s2.0-0033531765 (Pubitemid 29194048)
52. Ma J., Giovannucci E., Pollak M., Leavitt A., Tao Y., Gaziano J. M., Stampfer M. J., A prospective study of plasma C-peptide and colorectal cancer risk in men. Journal of the National Cancer Institute 2004 96 7 546 553 2-s2.0-1842866389 (Pubitemid 38559579)
53. Ennishi D., Shitara K., Ito H., Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population. Cancer Science 2011 102 12 2231 2235
54. Shitara K., Ito S., Misawa K., Genetic polymorphism of IGF-1 predicts recurrence in patients with gastric cancer who have undergone curative gastrectomy. Annals of Oncology 2012 23 3 659 664
55. Schneider M. B., Matsuzaki H., Haorah J., Ulrich A., Standop J., Ding X. Z., Adrian T. E., Pour P. M., Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 2001 120 5 1263 1270 2-s2.0-0035082644 (Pubitemid 32246678)
56. Kato K., Gong J., Iwama H., The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo. Molecular Cancer Therapeutics 2012 11 3 549 560
57. Tilg H., Moschen A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 2006 6 10 772 783 2-s2.0-33748992313 10.1038/nri1937 (Pubitemid 44453463)
58. Kadowaki T., Yamauchi T., Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 3 439 451 2-s2.0-18844432308 10.1210/er.2005-0005 (Pubitemid 40686653)
59. Rose D. P., Komninou D., Stephenson G. D., Obesity, adipocytokines, and insulin resistance in breast cancer. Obesity Reviews 2004 5 3 153 165 2-s2.0-3242883351 10.1111/j.1467-789X.2004.00142.x (Pubitemid 38998240)
60. Ishikawa M., Kitayama J., Kazama S., Hiramatsu T., Hatano K., Nagawa H., Plasma adiponectin and gastric cancer. Clinical Cancer Research 2005 11 2 I 466 472 2-s2.0-12244295757 (Pubitemid 40116868)
61. Saxena N. K., Fu P. P., Nagalingam A., Wang J., Handy J., Cohen C., Tighiouart M., Sharma D., Anania F. A., Adiponectin modulates C-Jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology 2010 139 5 1762 1773 2-s2.0-78049478003 10.1053/j.gastro.2010. 07.001
62. Mutoh M., Teraoka N., Takasu S., Takahashi M., Onuma K., Yamamoto M., Kubota N., Iseki T., Kadowaki T., Sugimura T., Wakabayashi K., Loss of adiponectin promotes intestinal carcinogenesis in min and wild-type mice. Gastroenterology 2011 140 7 2000 2008 2-s2.0-79958121124 10.1053/j.gastro.2011. 02.019
63. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 2006 116 7 1784 1792 2-s2.0-33745834319 10.1172/JCI29126 (Pubitemid 44033298)
64. Kim A. Y., Lee Y. S., Kim K. H., Lee J. H., Lee H. K., Jang S. H., Kim S. E., Lee G. Y., Lee J. W., Jung S. A., Chung H. Y., Jeong S., Kim J. B., Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Molecular Endocrinology 2010 24 7 1441 1452 2-s2.0-77954828973 10.1210/me.2009-0498
65. Barb D., Williams C. J., Neuwirth A. K., Mantzoros C. S., Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. The American Journal of Clinical Nutrition 2007 86 3 s858 866 2-s2.0-40349108448
66. Yoneda K., Tomimoto A., Endo H., Iida H., Sugiyama M., Takahashi H., Mawatari H., Nozaki Y., Fujita K., Yoneda M., Inamori M., Nakajima N., Wada K., Nagashima Y., Nakagama H., Uozaki H., Fukayama M., Nakajima A., Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncology Reports 2008 20 3 479 483 2-s2.0-54549087818 10.3892/or-00000031
67. Cummings D. E., Foster K. E., Ghrelin-Leptin tango in body-weight regulation. Gastroenterology 2003 124 5 1532 1535 2-s2.0-0038297412 10.1016/S0016-5085(03)00350-0 (Pubitemid 36531824)
68. Stattin P., Palmqvist R., Söderberg S., Biessy C., Ardnor B., Hallmans G., Kaaks R., Olsson T., Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncology Reports 2003 10 6 2015 2021 2-s2.0-0742277837
69. Stattin P., Lukanova A., Biessy C., Söderberg S., Palmqvist R., Kaaks R., Olsson T., Jellum E., Obesity and colon cancer: does leptin provide a link? International Journal of Cancer 2004 109 1 149 152 2-s2.0-0742270445 10.1002/ijc.11668 (Pubitemid 38160676)
70. Endo H., Hosono K., Uchiyama T., Sakai E., Sugiyama M., Takahashi H., Nakajima N., Wada K., Takeda K., Nakagama H., Nakajima A., Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 2011 60 10 1363 1371 2-s2.0-79952567406 10.1136/gut.2010.235754
71. Somasundar P., McFadden D. W., Hileman S. M., Vona-Davis L., Leptin is a growth factor in cancer. Journal of Surgical Research 2004 116 2 337 349 2-s2.0-0842328722 10.1016/j.jss.2003.09.004 (Pubitemid 38175325)
72. Meier U., Gressner A. M., Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clinical Chemistry 2004 50 9 1511 1525 2-s2.0-4344607526 10.1373/clinchem.2004.032482 (Pubitemid 39121218)
73. Kusminski C. M., McTernan P. G., Kumar S., Role of resistin in obesity, insulin resistance and Type II diabetes. Clinical Science 2005 109 3 243 256 2-s2.0-25144447626 10.1042/CS20050078 (Pubitemid 41337128)
74. Wozniak S. E., Gee L. L., Wachtel M. S., Frezza E. E., Adipose tissue: the new endocrine organ? a review article. Digestive Diseases and Sciences 2009 54 9 1847 1856 2-s2.0-68249135718 10.1007/s10620-008-0585-3
75. Steppan C. M., Lazar M. A., The current biology of resistin. Journal of Internal Medicine 2004 255 4 439 447 2-s2.0-1842506529 10.1111/j.1365-2796.2004. 01306.x (Pubitemid 38446357)
76. Gonullu G., Kahraman H., Bedir A., Bektas A., Yücel I., Association between adiponectin, resistin, insulin resistance, and colorectal tumors. International Journal of Colorectal Disease 2010 25 2 205 212 2-s2.0-77649231695 10.1007/s00384-009-0828-6
77. Das U. N., Is obesity an inflammatory condition? Nutrition 2001 17 11-12 953 966 2-s2.0-0035666553 10.1016/S0899-9007(01)00672-4 (Pubitemid 34020662)
78. Schäffler A., Müller-Ladner U., Schölmerich J., Büchler C., Role of adipose tissue as an inflammatory organ in human diseases. Endocrine Reviews 2006 27 5 449 467 2-s2.0-33747076885 10.1210/er.2005-0022 (Pubitemid 44213227)
79. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003 112 12 1821 1830 2-s2.0-9144223683 10.1172/JCI200319451 (Pubitemid 38063705)
80. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
81. Neels J. G., Olefsky J. M., Inflamed fat: what starts the fire? Journal of Clinical Investigation 2006 116 1 33 35 2-s2.0-31044447347 10.1172/JCI27280 (Pubitemid 43121788)
82. Balkwill F., Cancer and the chemokine network. Nature Reviews Cancer 2004 4 7 540 550 2-s2.0-3042822267 (Pubitemid 38868623)
83. Corley D. A., Kubo A., Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. American Journal of Gastroenterology 2006 101 11 2619 2628 2-s2.0-33750528401 10.1111/j.1572-0241. 2006.00849.x (Pubitemid 44665262)
84. Hampel H., Abraham N. S., El-Serag H. B., Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Annals of Internal Medicine 2005 143 3 199 211 2-s2.0-23044493202 (Pubitemid 41076753)
85. Abnet C. C., Freedman N. D., Hollenbeck A. R., Fraumeni J. F., Leitzmann M., Schatzkin A., A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. European Journal of Cancer 2008 44 3 465 471 2-s2.0-38749083376 10.1016/j.ejca.2007.12.009
86. Kubo A., Corley D. A., Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiology Biomarkers and Prevention 2006 15 5 872 878 2-s2.0-33744732468 10.1158/1055-9965.EPI-05-0860 (Pubitemid 43823511)
87. John B. J., Irukulla S., Abulafi A. M., Kumar D., Mendall M. A., Systematic review: adipose tissue, obesity and gastrointestinal diseases. Alimentary Pharmacology and Therapeutics 2006 23 11 1511 1523 2-s2.0-33646592565 10.1111/j.1365-2036.2006.02915.x (Pubitemid 43727458)
88. Considine R. V., Sinha M. K., Heiman M. L., Kriauciunas A., Stephens T. W., Nyce M. R., Ohannesian J. P., Marco C. C., Mckee L. J., Bauer T. L., Caro J. F., Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine 1996 334 5 292 295 2-s2.0-13344295079 10.1056/NEJM199602013340503 (Pubitemid 26033933)
89. Ogunwobi O., Mutungi G., Beales I. L. P., Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 2006 147 9 4505 4516 2-s2.0-33747615242 10.1210/en.2006-0224 (Pubitemid 44268402)
90. Howard J. M., Beddy P., Ennis D., Keogan M., Pidgeon G. P., Reynolds J. V., Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. British Journal of Surgery 2010 97 7 1020 1027 2-s2.0-77953643031 10.1002/bjs.7072
91. Ryan A. M., Duong M., Healy L., Ryan S. A., Parekh N., Reynolds J. V., Power D. G., Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. Cancer Epidemiology 2011 35 4 309 319 2-s2.0-79960616415 10.1016/j.canep.2011.03.001
92. Greer K. B., Thompson C. L., Brenner L., Association of insulin and insulin-like growth factors with Barrett's oesophagus. Gut 2012 61 5 665 672
93. Yang P., Zhou Y., Chen B., Wan H. W., Jia G. Q., Bai H. L., Wu X. T., Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. European Journal of Cancer 2009 45 16 2867 2873 2-s2.0-70350010461 10.1016/j.ejca.2009.04.019
94. Kulig J., Sierzega M., Kolodziejczyk P., Dadan J., Drews M., Fraczek M., Jeziorski A., Krawczyk M., Starzynska T., Wallner G., Implications of overweight in gastric cancer: a multicenter study in a Western patient population. European Journal of Surgical Oncology 2010 36 10 969 976 2-s2.0-77957140690 10.1016/j.ejso.2010.07.007
95. Mizoue T., Inoue M., Wakai K., Nagata C., Shimazu T., Tsuji I., Otani T., Tanaka K., Matsuo K., Tamakoshi A., Sasazuki S., Tsugane S., Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. American Journal of Epidemiology 2008 167 12 1397 1406 2-s2.0-46249119188
96. Harnack L., Jacobs D. R. Jr., Nicodemus K., Lazovich D., Anderson K., Folsom A. R., Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutrition and Cancer 2002 43 2 152 158 2-s2.0-0036969176 (Pubitemid 36134089)
97. Giovannucci E., Rimm E. B., Ascherio A., Stampfer M. J., Colditz G. A., Willett W. C., Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. Journal of the National Cancer Institute 1995 87 4 265 273 2-s2.0-0028921519
98. Calle E. E., Obesity and cancer. British Medical Journal 2007 335 7630 1107 1108 2-s2.0-37049004171 10.1136/bmj.39384.472072.80 (Pubitemid 350247271)
99. Chan D. S. M., Lau R., Aune D., Vieira R., Greenwood D. C., Kampman E., Norat T., Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS ONE 2011 6 6 2-s2.0-79958157809 10.1371/journal.pone.0020456 e20456
100. Norat T., Bingham S., Ferrari P., Meat, fish, and colorectal cancer risk. The European prospective investigation into cancer and nutrition. Journal of the National Cancer Institute 2005 97 23 1787 1789 2-s2.0-28944434197 10.1093/jnci/dji407 (Pubitemid 41782290)
101. Chiu H. M., Lin J. T., Shun C. T., Liang J. T., Lee Y. C., Huang S. P., Wu M. S., Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm. Clinical Gastroenterology and Hepatology 2007 5 2 221 229 2-s2.0-33846890892 10.1016/j.cgh.2006.06.022 (Pubitemid 46223651)
102. Bowers K., Albanes D., Limburg P., Pietinen P., Taylor P. R., Virtamo J., Stolzenberg-Solomon R., A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. American Journal of Epidemiology 2006 164 7 652 664 2-s2.0-33748995104 10.1093/aje/kwj253 (Pubitemid 44453494)
103. Kim B. C., Shin A., Hong C. W., Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes & Control 2012 23 5 727 735
104. El-Serag H. B., Tran T., Everhart J. E., Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004 126 2 460 468 2-s2.0-0842321807 10.1053/j.gastro.2003.10.065 (Pubitemid 38182303)
105. Jee S. H., Ohrr H., Sull J. W., Fasting serum glucose level and cancer risk in Korean men and women. Journal of the American Medical Association 2005 293 2 194 202 2-s2.0-11844259994 10.1001/jama.293.2.194 (Pubitemid 40095870)
106. Wang C., Wang X., Gong G., Ben Q., Qiu W., Chen Y., Li G., Wang L., Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. International Journal of Cancer 2011 130 6 1639 1648 2-s2.0-79960653870 10.1002/ijc.26165
107. Bugianesi E., Leone N., Vanni E., Marchesini G., Brunello F., Carucci P., Musso A., De Paolis P., Capussotti L., Salizzoni M., Rizzetto M., Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002 123 1 134 140 2-s2.0-0036302288 10.1053/gast.2002.34168 (Pubitemid 34747534)
108. Siegel A. B., Zhu A. X., Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 2009 115 24 5651 5661 2-s2.0-73149120271 10.1002/cncr.24687
109. Peng N. F., Li L. Q., Qin X., Guo Y., Peng T., Xiao K. Y., Chen X. G., Yang Y. F., Su Z. X., Chen B., Su M., Qi L. N., Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of Hepatitis B virus. Annals of Surgical Oncology 2011 18 5 1258 1266 2-s2.0-79955812260 10.1245/s10434-010-1458-5
110. Jing W., Jin G., Zhou X., Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis. European Journal of Cancer Prevention 2012 21 1 24 31
111. Duell E. J., Holly E. A., Bracci P. M., Liu M., Wiencke J. K., Kelsey K. T., A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. Journal of the National Cancer Institute 2002 94 4 297 306 2-s2.0-0037138735 (Pubitemid 34196324)
112. Fuchs C. S., Colditz G. A., Stampfer M. J., Giovannucci E. L., Hunter D. J., Rimm E. B., Willett W. C., Speizer F. E., A prospective study of cigarette smoking and the risk of pancreatic cancer. Archives of Internal Medicine 1996 156 19 2255 2260 2-s2.0-0029805031 10.1001/archinte.156.19.2255 (Pubitemid 26361920)
113. Michaud D. S., Giovannucci E., Willett W. C., Colditz G. A., Stampfer M. J., Fuchs C. S., Physical activity, obesity, height, and the risk of pancreatic cancer. Journal of the American Medical Association 2001 286 8 921 929 2-s2.0-0035934044 (Pubitemid 33010338)
114. Stolzenberg-Solomon R. Z., Adams K., Leitzmann M., Schairer C., Michaud D. S., Hollenbeck A., Schatzkin A., Silverman D. T., Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP diet and health cohort. American Journal of Epidemiology 2008 167 5 586 597 2-s2.0-40049112404 10.1093/aje/kwm361 (Pubitemid 351323320)
115. Luo J., Margolis K. L., Adami H. O., LaCroix A., Ye W., Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States). British Journal of Cancer 2008 99 3 527 531 2-s2.0-48349136530 10.1038/sj.bjc.6604487
116. Li D., Morris J. S., Liu J., Hassan M. M., Day R. S., Bondy M. L., Abbruzzese J. L., Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. Journal of the American Medical Association 2009 301 24 2553 2562 2-s2.0-67649227786 10.1001/jama.2009.886
117. O'Rorke M. A., Cantwell M. M., Cardwell C. R., Mulholland H. G., Murray L. J., Can physical activity modulate pancreatic cancer risk? A systematic review and meta-analysis. International Journal of Cancer 2010 126 12 2957 2968 2-s2.0-77951883869 10.1002/ijc.24997
118. McWilliams R. R., Matsumoto M. E., Burch P. A., Kim G. P., Halfdanarson T. R., De Andrade M., Reid-Lombardo K., Bamlet W. R., Obesity adversely affects survival in pancreatic cancer patients. Cancer 2010 116 21 5054 5062 2-s2.0-78249288802 10.1002/cncr.25465
119. Parker E. D., Folsom A. R., Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study. International Journal of Obesity 2003 27 12 1447 1452 2-s2.0-0348141028 10.1038/sj.ijo.0802437 (Pubitemid 38019155)